Xilio Therapeutics, Inc. (XLO) Reports 26% Response in Colon Cancer Drug Trial
Xilio Therapeutics, Inc.
Xilio Therapeutics Inc. (XLO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Ghisallo Capital Management Michael Germino | 1,333,000 | $906,307 | 0.02% | |
| 2. | Squarepoint Ops LLC Maxime Fortin (Cio) | 235,456 | $160,087 | 0% | |
| 3. | Balyasny Asset Management Dmitry Balyasny | 198,859 | $135,204 | -22% | 0% |
| 4. | Renaissance Technologies Jim Simons | 164,200 | $111,640 | -8% | 0% |
| 5. | Millennium Management Israel Englander | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.69 | 25,000 | $17,215.00 | 70,000 | 2025-06-17 | Filing | |
| $0.69 | 45,000 | $30,870.00 | 45,000 | 2025-06-16 | Filing | |
| $0.68 | 36,289 | $24,680.15 | 281,172 | 2025-06-16 | Filing | |
| $1.04 | 1,759,978 | $1,830,377.12 | 9,105,451 | 2024-12-18 | Filing | |
| $0.76 | 485,250 | $368,790.00 | 7,345,473 | 2024-04-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.98 | 6,954 | $6,840.65 | 12,421 | 2025-01-02 | Filing | |
| $0.98 | 1,803 | $1,773.61 | 3,197 | 2025-01-02 | Filing | |
| $0.64 | 267 | $170.88 | 734,546 | 2024-02-08 | Filing | |
| $0.64 | 733 | $469.12 | 2,019,563 | 2024-02-08 | Filing | |
| $0.83 | 560 | $464.80 | 734,813 | 2024-01-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,105,451 | $6,190,796 | 0.48% | |
| 2. | 4,566,817 | $3,104,979 | 0.39% | |
| 3. | 1,483,758 | $1,008,807 | 0.47% | |
| 4. | 1,475,121 | $1,002,935 | 5.13% | |
| 5. | 1,444,326 | $981,997 | 0% |
News See All
